NCT05058638View on ClinicalTrials.gov

Effectiveness of Aquamin® in Mitigating Halitosis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
HealthyHalitosis
Interventions
DRUG

Aquamin

Participants will take a 90-day supply of Aquamin®, 4 capsules per day; 2 to be taken in the morning and 2 in the evening (containing approximately 800 mg calcium/day).

Trial Locations (1)

48109

University of Michigan School of Dentistry, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER